...
首页> 外文期刊>Medicinal chemistry >Mevalonolactone: An inhibitor of Staphylococcus Epidermidis adherence and biofilm formation
【24h】

Mevalonolactone: An inhibitor of Staphylococcus Epidermidis adherence and biofilm formation

机译:甲羟戊酸内酯:表皮葡萄球菌粘附和生物膜形成的抑制剂

获取原文
获取原文并翻译 | 示例

摘要

Staphylococcus epidermidis, a commensal microorganism at the human skin and mucosae, is nowadays considered an important opportunistic pathogen related to nosocomial infections on indwelling medical devices due biofilm formation. Bacterial biofilms are the worst aspect in the treatment of infections and now efforts have been made in the search for new molecular entities to overcome this situation. In this work, a compound isolated from marine associated fungi was capable to interfere with the adherence and biofilm formation of S. epidermidis. This compound, identified as mevalonolactone, showed significant inhibition of S. epidermidis ATCC 35984 biofilm formation, without antibacterial activity, evaluated by crystal violet assay, turbidimetric assay and scanning electron microscopy. When assayed against 12 clinical isolates of S. epidermidis, this compound exhibited both biofilm inhibition and antimicrobial activity, but no activity against gram-negative bacteria was observed. Therefore, when this constitutive molecule is added in the antibiofilm and antibacterial assays, it might act as an important agent against this pathogen, contributing to the arsenal of antibiofilm compounds.
机译:葡萄球菌表皮葡萄球菌是人类皮肤和粘膜上的常见微生物,如今被认为是重要的机会病原体,与由于生物膜形成而在留置医疗设备上的医院感染有关。细菌生物膜是感染治疗中最糟糕的方面,现在人们已经在努力寻找新的分子实体来克服这种情况。在这项工作中,从海洋相关真菌中分离出的化合物能够干扰表皮葡萄球菌的粘附和生物膜形成。通过结晶紫测定,比浊测定和扫描电子显微镜评估,该化合物被鉴定为甲羟戊内酯,对表皮葡萄球菌ATCC 35984生物膜形成具有显着抑制作用,而没有抗菌活性。当针对12种表皮葡萄球菌临床分离株进行分析时,该化合物既具有生物膜抑制作用,又具有抗菌活性,但未观察到针对革兰氏阴性菌的活性。因此,当在抗生物膜和抗菌测定中加入该组成分子时,它可能是抵抗这种病原体的重要药物,有助于抗生物膜化合物的库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号